Market Analysis and Insights: Global Computational Medicine and Drug Designing Software Market
The global Computational Medicine and Drug Designing Software market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Computational Medicine and Drug Designing Software market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Computational Medicine and Drug Designing Software, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Computational Medicine and Drug Designing Software, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Computational Medicine and Drug Designing Software revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Computational Medicine and Drug Designing Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Computational Medicine and Drug Designing Software revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Segment by Type
Cloud-based
On-premise
Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Computational Medicine and Drug Designing Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Medicine and Drug Designing Software companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computational Medicine and Drug Designing Software revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cloud-based
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Discovery and Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modeling
1.3.5 Medical Imaging
1.3.6 Predictive Analysis of Drug Targets
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2019-2030)
2.2 Global Computational Medicine and Drug Designing Software Growth Trends by Region
2.2.1 Computational Medicine and Drug Designing Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2019-2024)
2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2025-2030)
2.3 Computational Medicine and Drug Designing Software Market Dynamics
2.3.1 Computational Medicine and Drug Designing Software Industry Trends
2.3.2 Computational Medicine and Drug Designing Software Market Drivers
2.3.3 Computational Medicine and Drug Designing Software Market Challenges
2.3.4 Computational Medicine and Drug Designing Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Computational Medicine and Drug Designing Software by Players
3.1.1 Global Computational Medicine and Drug Designing Software Revenue by Players (2019-2024)
3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2019-2024)
3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Computational Medicine and Drug Designing Software, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio
3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2023
3.5 Global Key Players of Computational Medicine and Drug Designing Software Head office and Area Served
3.6 Global Key Players of Computational Medicine and Drug Designing Software, Product and Application
3.7 Global Key Players of Computational Medicine and Drug Designing Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Designing Software Breakdown Data by Type
4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2019-2024)
4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2025-2030)
5 Computational Medicine and Drug Designing Software Breakdown Data by Application
5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2019-2024)
5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Computational Medicine and Drug Designing Software Market Size (2019-2030)
6.2 North America Computational Medicine and Drug Designing Software Market Size by Type
6.2.1 North America Computational Medicine and Drug Designing Software Market Size by Type (2019-2024)
6.2.2 North America Computational Medicine and Drug Designing Software Market Size by Type (2025-2030)
6.2.3 North America Computational Medicine and Drug Designing Software Market Share by Type (2019-2030)
6.3 North America Computational Medicine and Drug Designing Software Market Size by Application
6.3.1 North America Computational Medicine and Drug Designing Software Market Size by Application (2019-2024)
6.3.2 North America Computational Medicine and Drug Designing Software Market Size by Application (2025-2030)
6.3.3 North America Computational Medicine and Drug Designing Software Market Share by Application (2019-2030)
6.4 North America Computational Medicine and Drug Designing Software Market Size by Country
6.4.1 North America Computational Medicine and Drug Designing Software Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)
6.4.3 North America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Designing Software Market Size (2019-2030)
7.2 Europe Computational Medicine and Drug Designing Software Market Size by Type
7.2.1 Europe Computational Medicine and Drug Designing Software Market Size by Type (2019-2024)
7.2.2 Europe Computational Medicine and Drug Designing Software Market Size by Type (2025-2030)
7.2.3 Europe Computational Medicine and Drug Designing Software Market Share by Type (2019-2030)
7.3 Europe Computational Medicine and Drug Designing Software Market Size by Application
7.3.1 Europe Computational Medicine and Drug Designing Software Market Size by Application (2019-2024)
7.3.2 Europe Computational Medicine and Drug Designing Software Market Size by Application (2025-2030)
7.3.3 Europe Computational Medicine and Drug Designing Software Market Share by Application (2019-2030)
7.4 Europe Computational Medicine and Drug Designing Software Market Size by Country
7.4.1 Europe Computational Medicine and Drug Designing Software Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)
7.4.3 Europe Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Computational Medicine and Drug Designing Software Market Size (2019-2030)
8.2 China Computational Medicine and Drug Designing Software Market Size by Type
8.2.1 China Computational Medicine and Drug Designing Software Market Size by Type (2019-2024)
8.2.2 China Computational Medicine and Drug Designing Software Market Size by Type (2025-2030)
8.2.3 China Computational Medicine and Drug Designing Software Market Share by Type (2019-2030)
8.3 China Computational Medicine and Drug Designing Software Market Size by Application
8.3.1 China Computational Medicine and Drug Designing Software Market Size by Application (2019-2024)
8.3.2 China Computational Medicine and Drug Designing Software Market Size by Application (2025-2030)
8.3.3 China Computational Medicine and Drug Designing Software Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Computational Medicine and Drug Designing Software Market Size (2019-2030)
9.2 Asia Computational Medicine and Drug Designing Software Market Size by Type
9.2.1 Asia Computational Medicine and Drug Designing Software Market Size by Type (2019-2024)
9.2.2 Asia Computational Medicine and Drug Designing Software Market Size by Type (2025-2030)
9.2.3 Asia Computational Medicine and Drug Designing Software Market Share by Type (2019-2030)
9.3 Asia Computational Medicine and Drug Designing Software Market Size by Application
9.3.1 Asia Computational Medicine and Drug Designing Software Market Size by Application (2019-2024)
9.3.2 Asia Computational Medicine and Drug Designing Software Market Size by Application (2025-2030)
9.3.3 Asia Computational Medicine and Drug Designing Software Market Share by Application (2019-2030)
9.4 Asia Computational Medicine and Drug Designing Software Market Size by Region
9.4.1 Asia Computational Medicine and Drug Designing Software Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Computational Medicine and Drug Designing Software Market Size by Region (2019-2024)
9.4.3 Asia Computational Medicine and Drug Designing Software Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type
10.2.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application
10.3.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country
10.4.1 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Details
11.1.2 Entelos Business Overview
11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction
11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.1.5 Entelos Recent Developments
11.2 Crown Bioscience
11.2.1 Crown Bioscience Company Details
11.2.2 Crown Bioscience Business Overview
11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction
11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.2.5 Crown Bioscience Recent Developments
11.3 Chemical Computing Group
11.3.1 Chemical Computing Group Company Details
11.3.2 Chemical Computing Group Business Overview
11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction
11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.3.5 Chemical Computing Group Recent Developments
11.4 Nimbus Therapeutics
11.4.1 Nimbus Therapeutics Company Details
11.4.2 Nimbus Therapeutics Business Overview
11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction
11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.4.5 Nimbus Therapeutics Recent Developments
11.5 Schrodinger
11.5.1 Schrodinger Company Details
11.5.2 Schrodinger Business Overview
11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction
11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.5.5 Schrodinger Recent Developments
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Details
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction
11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.6.5 Dassault Systemes Recent Developments
11.7 Genedata
11.7.1 Genedata Company Details
11.7.2 Genedata Business Overview
11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction
11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.7.5 Genedata Recent Developments
11.8 Biognos
11.8.1 Biognos Company Details
11.8.2 Biognos Business Overview
11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction
11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.8.5 Biognos Recent Developments
11.9 Leadscope
11.9.1 Leadscope Company Details
11.9.2 Leadscope Business Overview
11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction
11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.9.5 Leadscope Recent Developments
11.10 Rhenovia Pharma Limited
11.10.1 Rhenovia Pharma Limited Company Details
11.10.2 Rhenovia Pharma Limited Business Overview
11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction
11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.10.5 Rhenovia Pharma Limited Recent Developments
11.11 Compugen
11.11.1 Compugen Company Details
11.11.2 Compugen Business Overview
11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction
11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.11.5 Compugen Recent Developments
11.12 Certara LP
11.12.1 Certara LP Company Details
11.12.2 Certara LP Business Overview
11.12.3 Certara LP Computational Medicine and Drug Designing Software Introduction
11.12.4 Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.12.5 Certara LP Recent Developments
11.13 Prosarix
11.13.1 Prosarix Company Details
11.13.2 Prosarix Business Overview
11.13.3 Prosarix Computational Medicine and Drug Designing Software Introduction
11.13.4 Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.13.5 Prosarix Recent Developments
11.14 Simulations Plus
11.14.1 Simulations Plus Company Details
11.14.2 Simulations Plus Business Overview
11.14.3 Simulations Plus Computational Medicine and Drug Designing Software Introduction
11.14.4 Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.14.5 Simulations Plus Recent Developments
11.15 Strand Life Sciences
11.15.1 Strand Life Sciences Company Details
11.15.2 Strand Life Sciences Business Overview
11.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Introduction
11.15.4 Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.15.5 Strand Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
听
听
*If Applicable.
